Position in PCVX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$112,888
-$2,830,383 QoQ
Shares Held
1,942
-96.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#236
of 329 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Derivatives in PCVX
reported options exposure · as of Jun 30, 2026CallValue
$116,260
CallShares
2,000
PutValue
$313,902
PutShares
5,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names. PCVX ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in PCVX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,260 | 2,000 | Call | Sole | 2026-08-03 | |
| 2026-06-30 | $112,888 | 1,942 | Shares | Sole | 2026-08-03 | |
| 2026-06-30 | $313,902 | 5,400 | Put | Sole | 2026-08-03 | |
| 2026-03-31 | $127,842 | 2,200 | Put | Sole | 2026-05-13 | |
| 2026-03-31 | $2,943,271 | 50,650 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $683,102 | 14,805 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $11,788,451 | 362,610 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,001,276 | 105,966 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,144,422 | 148,356 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $65,488 | 800 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $91,416 | 800 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $6,652,342 | 58,216 | Shares | Sole | 2024-11-14 | |
| 2024-03-31 | $2,029,285 | 29,707 | Shares | Sole | 2024-05-15 | |
| 2024-03-31 | $54,648 | 800 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $95,634 | 1,400 | Call | Sole | 2024-05-15 | |
| 2023-12-31 | $50,240 | 800 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $7,154,238 | 113,921 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $64,922 | 1,300 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | $89,892 | 1,800 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $2,948,507 | 59,041 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,293,854 | 87,883 | Shares | Sole | 2023-05-15 | |
| 2023-03-31 | $48,724 | 1,300 | Call | Sole | 2023-05-15 | |
| 2022-12-31 | $201,390 | 4,200 | Put | Sole | 2023-02-14 | |
| 2022-12-31 | $6,867,207 | 143,216 | Shares | Sole | 2023-02-14 | |
| 2022-12-31 | $124,670 | 2,600 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $1,422,240 | 59,260 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,549,600 | 163,125 | Shares | Sole | 2022-08-19 | |
| 2022-03-31 | $1,677,265 | 69,452 | Shares | Sole | 2022-05-27 | |
| No filing history on record for this holder in this stock. | ||||||